Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Schwerzmann
Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) for Thromboembolic Prevention, Are They Safe in Congenital Heart Disease? Results of a Worldwide Study
International Journal of Cardiology
Cardiovascular Medicine
Cardiology
Related publications
Pharmacological Profile of Non-Vitamin K Antagonist Oral Anticoagulants
African Journal of Pharmacy and Pharmacology
Pcv135 - Non-Vitamin K Antagonist Oral Anticoagulants Prescription Monitoring: How to Optimize Vigilance in Stroke Prevention
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Use of Non-Vitamin K Antagonist Oral Anticoagulants 2008-2016: A Danish Nationwide Cohort Study
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Safety of Once- Or Twice-Daily Dosing of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients With Nonvalvular Atrial Fibrillation: A NOAC-TR Study
Bosnian Journal of Basic Medical Sciences
Medicine
Cryptogenic Stroke Prevention Through Venous Thromboembolism Prevention: Potential and Truth in the Advent of Non-Vitamin K Antagonist Oral Anticoagulants
Journal of Cardiology Cases
Cardiovascular Medicine
Cardiology
Effective Management of Venous Thromboembolism in the Community: Non-Vitamin K Antagonist Oral Anticoagulants
International Journal of General Medicine
Medicine
Role of Non-Vitamin K Oral Anticoagulants for Prevention of Stroke in Renal Impaired Atrial Fibrillation Patients
ACI (Acta Cardiologia Indonesiana)
A Cost-Effectiveness Analysis of Novel Oral Anticoagulants for Primary Prevention of Venous Thromboembolic Disease
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Overview of the Non-Vitamin K Oral Anticoagulants for Atrial Fibrillation
Therapeutic Advances in Cardiovascular Disease
Cardiovascular Medicine
Pharmacology
Cardiology
